High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill

Launched by REGION STOCKHOLM · May 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new device called Optiflow Switch, which is designed to improve the safety of a procedure called intubation in critically ill patients. Intubation is when a tube is placed in the airway to help someone breathe, and it can sometimes lead to problems like low oxygen levels and heart instability. The trial aims to see if using the Optiflow Switch for pre-oxygenation (getting the patient’s oxygen levels up before the procedure) and during the intubation can reduce these risks compared to traditional methods, such as using a tight mask.

To participate in this trial, you must be an adult aged 18 or older who is currently in the intensive care unit and needs intubation for any reason. However, there are some exclusions: if you have facial injuries that make it hard to use a nasal device, if you are pregnant, have a complete blockage of your nose, or if the medical team decides for any other reason that you shouldn't participate, you won't be eligible. If you join the trial, you can expect to receive either the new device or the traditional method during your intubation, and your medical team will monitor you closely for any issues. This study is currently recruiting participants, and your involvement could help improve care for future patients who need intubation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult, ≥18 years old
• • Intensive care patients that require tracheal intubation for any indication
• Exclusion Criteria:
• • Patients with skull or facial injuries where the application of nasal cannula is to be avoided, decided by the intensivist.
• • Pregnancy
• • Total nasal obstruction
• • Deemed not suitable for any other reason than the aforementioned